BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19539054)

  • 41. [Clostridium difficile infection. The nosocomial aspect].
    Bucher A; Nordbø G
    Tidsskr Nor Laegeforen; 1995 Apr; 115(11):1361-4. PubMed ID: 7770832
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New views on Clostridium difficile infections: Introduction.
    Rodloff A; Gould I
    Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S1. PubMed ID: 19303561
    [No Abstract]   [Full Text] [Related]  

  • 43. Update on Clostridium difficile infection.
    O'Donoghue C; Kyne L
    Curr Opin Gastroenterol; 2011 Jan; 27(1):38-47. PubMed ID: 21099432
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Infection control measures to limit the spread of Clostridium difficile.
    Vonberg RP; Kuijper EJ; Wilcox MH; Barbut F; Tüll P; Gastmeier P; ; ; van den Broek PJ; Colville A; Coignard B; Daha T; Debast S; Duerden BI; van den Hof S; van der Kooi T; Maarleveld HJ; Nagy E; Notermans DW; O'Driscoll J; Patel B; Stone S; Wiuff C
    Clin Microbiol Infect; 2008 May; 14 Suppl 5():2-20. PubMed ID: 18412710
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of Clostridium difficile strains isolated from immunosuppressed inpatients in a hospital in Rio de Janeiro, Brazil.
    Balassiano IT; Miranda KR; Boente RF; Pauer H; Oliveira IC; Santos-Filho J; Amorim EL; Caniné GA; Souza CF; Gomes MZ; Ferreira EO; Brazier JS; Domingues RM
    Anaerobe; 2009 Jun; 15(3):61-4. PubMed ID: 19154793
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors.
    Sundram F; Guyot A; Carboo I; Green S; Lilaonitkul M; Scourfield A
    J Hosp Infect; 2009 Jun; 72(2):111-8. PubMed ID: 19386381
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clostridium difficile using DNA microarrays.
    Stabler R; Dawson L; Wren B
    Methods Mol Biol; 2010; 646():149-62. PubMed ID: 20597008
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antimicrobial susceptibility of Clostridium difficile clinical isolates collected from 2001 to 2007 in a French university hospital].
    Cattoir V; Ould-Hocine ZF; Legrand P
    Pathol Biol (Paris); 2008; 56(7-8):407-11. PubMed ID: 18845403
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of infections associated with Clostridium difficile].
    Szczesny A; Martirosian G
    Wiad Lek; 2003; 56(5-6):278-82. PubMed ID: 14526488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Has the severity of Clostridium difficile infections increased?
    Das I; Jumaa P
    J Hosp Infect; 2007 Jan; 65(1):85-6. PubMed ID: 17055114
    [No Abstract]   [Full Text] [Related]  

  • 51. [Diarrhea associated with Clostridium difficile. One-year retrospective study at a tertiary hospital].
    Barreiro PM; Pintor E; Rosario Burón M; Díaz B; Valverde J; de la Torre F
    Enferm Infecc Microbiol Clin; 1998 Oct; 16(8):359-63. PubMed ID: 9835150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunization strategies for Clostridium difficile infections.
    Rebeaud F; Bachmann MF
    Expert Rev Vaccines; 2012 Apr; 11(4):469-79. PubMed ID: 22551032
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clostridium difficile colitis].
    Eckert C; Lalande V; Barbut F
    Rev Prat; 2015 Jan; 65(1):21-5. PubMed ID: 25842418
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clostridium difficile infection and liver disease.
    Musa S; Moran C; Rahman T
    J Gastrointestin Liver Dis; 2010 Sep; 19(3):303-10. PubMed ID: 20922196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clostridium difficile: a European perspective.
    Jones AM; Kuijper EJ; Wilcox MH
    J Infect; 2013 Feb; 66(2):115-28. PubMed ID: 23103666
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular epidemiology of Clostridium difficile for clinical practice.
    Tschudin-Sutter S
    Swiss Med Wkly; 2014; 144():w13995. PubMed ID: 25207831
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clostridium difficile: development of a novel candidate vaccine.
    Foglia G; Shah S; Luxemburger C; Pietrobon PJ
    Vaccine; 2012 Jun; 30(29):4307-9. PubMed ID: 22682287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Clostridium difficile PCR ribotype 027 lineage: a pathogen on the move.
    Valiente E; Cairns MD; Wren BW
    Clin Microbiol Infect; 2014 May; 20(5):396-404. PubMed ID: 24621128
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clostridium difficile: familiar pathogen, changing epidemiology: a virulent strain has been appearing more often, even in patients not taking antibiotics.
    Todd B
    Am J Nurs; 2006 May; 106(5):33-6. PubMed ID: 16639241
    [No Abstract]   [Full Text] [Related]  

  • 60. A menace moves into the community.
    Lowen T
    Minn Med; 2012 Aug; 95(8):8-9. PubMed ID: 22953466
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.